Retreatment of Chronic Hepatitis C Infection with Telaprevir : Turkey Experience.

Pekgoz M., GÜREL S., KIYICI M., GÜLTEN M., Dolar E., NAK S. G.

Acta gastro-enterologica Belgica, cilt.79, sa.1, ss.18-22, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 79 Sayı: 1
  • Basım Tarihi: 2016
  • Dergi Adı: Acta gastro-enterologica Belgica
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.18-22
  • Anahtar Kelimeler: Hepatitis C, Telaprevir, triple treatment, sustained virologic response, RIBAVIRIN, PEGINTERFERON, ALPHA-2A
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background/Aims : Patients with genotype 1 chronic hepatitis C virus (HCV) who do not have a sustained virologic response to therapy with peginterferon alfa and ribavirin have a low likelihood of success with retreatment.